Researchers have completed the first gene therapy procedure aimed at stoping age-related macular degeneration. Dr. Allen Ho commented, “What’s unique about this particular clinical trial is that they are trying gene therapy surgically delivered to the sub retinal space to try to modify the disease process of dry macular degeneration." Read the full article from... read more
Diabetic retinopathy is the most common cause of vision loss among people with diabetes and is the most frequent cause of new cases of blindness among adults ages 20 to 74. Dr. Omesh Gupta discusses how treatments have radically improved in the recent years. Read the full article here from AARP.
Association of Intravitreal Anti–Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration
A study recently done out of the Mayo Clinic, looked into the risk of strokes due to anti-VEGF therapy for AMD. The study has found that there is no association between the two, and the use of anti-VEGF therapy is still the best option for patients with AMD. Dr. Carl Regillo added his own comment... read more
Dr. Sunir Garg, co-author of a study looking into how statins can help prevent diabetic retinopathy, says, “Statins may actually help patients’ eyeballs as well, not just their hearts.” Read more on this study about how people with diabetes could benefit from using statins to delay the risk of diabetic retinopathy.
Dr. Jason Hsu leads a study that looks into the loss of follow-up visits with patients suffering from non-proliferative diabetic retinopathy. The study has found that a quarter of patients do not return within a year of receiving an anti-VEGF injection. Read more about the study from Healio.
It might start with straight lines looking wavy. Or there might be a dark spot in the center of the person’s vision. A likely culprit: wet age-related macular degeneration, or wet AMD. Learn more from Dr. Allen Ho about Wet AMD at Philly.com.
The American Academy of Ophthalmology recently published an article that discusses how a new study shows that an eye scan may be a relatively easy, inexpensive way to test for early Alzheimer’s disease. Dr. Sunir Garg weighs in on using OCTA to detect changes in the retina, which have similarities to changes in Alzheimer’s disease. The retina is a direct extension from the brain. Read... read more
Everyone has had a pimple at some point in their life, but have you ever had one on your eyelid? Dr. Sunir Garg explains how eyelid pimples, better know as styes, can form and the different treatment methods to care for them in a safe way. Read the full article here in Women's Health.
With cell phones, TV’s and computer usage higher than ever, the risk of damaging your eyes from digital blue light exposure has increased. Dr. Sunir Garg discusses the chances of damaging your retina and the possibility of being diagnosed with Age-related Macular Degeneration later in life. Read the full article in Forbes, to learn how you could be at... read more
Dr. Carl Regillo, a study investigator for Genentech’s first refillable eye implant, discusses the promising results in a phase 2 trial. The Port Delivery System is designed to deliver a new formulation of Lucentis' active ingredient, ranibizumab, continuously to wet age-related macular degeneration patients to avoid monthly eye injections. Read more about the new surgical implant here.